CALCIMAR 200 UNIT
CALCITONIN (SALMON SYNTHETIC) : 200 UNIT · DIN 01926691 · SANOFI-AVENTIS CANADA INC
Health Canada status: MARKETED
What is CALCIMAR?
CALCIMAR 200 UNIT contains CALCITONIN (SALMON SYNTHETIC) : 200 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01926691, held by SANOFI-AVENTIS CANADA INC, supplied as SOLUTION for SUBCUTANEOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 13-Feb-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CALCIMAR used for?
Symptomatic Paget's disease (refractory to other treatments) and early treatment of hypercalcemic emergencies.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01926691 |
|---|---|
| Brand name | CALCIMAR |
| Generic / active ingredient | CALCITONIN (SALMON SYNTHETIC) : 200 UNIT |
| Manufacturer | SANOFI-AVENTIS CANADA INC |
| Strength | 200 UNIT |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | H05BA01 CALCITONIN (SALMON SYNTHETIC) |
| AHFS class | 68:24.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 13-Feb-2008 |
| Original market date | 1983-12-31 00:00:00 |
How is it administered?
Paget's: 100 IU/day SC/IM (min 50 IU 3x/week). Hypercalcemia: 4 IU/kg every 12h SC/IM, may increase to 8 IU/kg every 6-12h. Use shortest duration possible.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at refrigerator temperature (2-8°C). Stable for 2 weeks at controlled room temperature (15-30°C).
How is it supplied?
400 International Units per 2 mL multidose vial.
Contraindications
Hypersensitivity to CALCIMAR or to any ingredient in the formulation or component of the container.
Warnings and precautions
Increased risk of malignancies with long-term use. Potential for serious allergic-type reactions/anaphylaxis. Risk of hypocalcemic tetany. Limit treatment duration.
What can be used instead?
Other Canadian products sharing ATC code H05BA01 CALCITONIN (SALMON SYNTHETIC). 1 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CALCITONIN INJECTABLE | 200 UNIT | LIQUID | APOTEX INC | CANCELLED POST MARKET | DIN 02246058 |
| APO-CALCITONIN NASAL SPRAY | 200 UNIT | SOLUTION | APOTEX INC | CANCELLED POST MARKET | DIN 02247585 |
| CALCITONIN SALMON INJECTION USP | 200 UNIT | SOLUTION | STERIMAX INC | APPROVED | DIN 02383233 |
| CALTINE INJ 100 UNIT/ML (1ML AMP) | 100 UNIT | LIQUID | FERRING INC | CANCELLED POST MARKET | DIN 02007134 |
| CALTINE INJ 100UNIT/ML (0.5ML AMP) | 100 UNIT | LIQUID | FERRING INC | CANCELLED POST MARKET | DIN 01940376 |
| MIACALCIN INJECTION 200IU/ML | 200 UNIT | LIQUID | NOVARTIS PHARMACEUTICALS CANADA INC | APPROVED | DIN 02144301 |
| MIACALCIN NASAL SPRAY 200 IU | 200 UNIT | SPRAY | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 02240775 |
| PRO-CALCITONIN - 200 | 200 UNIT | SOLUTION | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02311046 |
| SANDOZ-CALCITONIN NS | 200 UNIT | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02261766 |
Who else supplies CALCITONIN (SALMON SYNTHETIC) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CALCITONIN (SALMON SYNTHETIC) appears in 9 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.